KRISCET

This brand name is authorized in Nigeria.

Active ingredients

The drug KRISCET contains one active pharmaceutical ingredient (API):

1	Cimetidine UNII 80061L1WGD - CIMETIDINE
	Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.
	Read more about Cimetidine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9284	Caplet	KRISCET-200 CAPLETS TAB 200 mg 2 X 10	34 RNW-PP-371581 KRISCET-200 CAPLETS CIMETIDINE 200MG CIMETIDINE 200MG A4-9284 Drugs Nigerian Products 2X10 Prescription Only Medicine (POM) 10/10/2023 KRISHAT PHARMA INDUSTRIES LIMITED, KM 15, LAGOS IBADAN EXPRESSWAY, IBADAN, OYO STATE, NIGERIA 8083636904 operations@krishatpharma.com KRISHAT PHARMA INDUSTRIES LTD, KM 15, LAGOS IBADAN EXPRESSWAY, OPP. ORIENTAL FOODS. IBADAN, OYO STATE, NIGERIA., Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BA01	Cimetidine	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists
Discover more medicines within A02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9283, A4-9284